BioAlliance Pharma Presents Results on Sitavig® at the 10th EADV Symposium
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Regulatory News:
BioAlliance Pharma SA (Euronext Paris - BIO), a Company dedicated to the development of orphan oncology products and supportive care products, has presented the results of the pharmacokinetic and pharmacodynamic study on Sitavig® at the 10th EADV spring symposium (European Academy of Dermatology and Venereology) in Cracow (Poland) on May 24, 2013.
Help employers find you! Check out all the jobs and post your resume.
Regulatory News:
BioAlliance Pharma SA (Euronext Paris - BIO), a Company dedicated to the development of orphan oncology products and supportive care products, has presented the results of the pharmacokinetic and pharmacodynamic study on Sitavig® at the 10th EADV spring symposium (European Academy of Dermatology and Venereology) in Cracow (Poland) on May 24, 2013.
Help employers find you! Check out all the jobs and post your resume.